Kymera Therapeutics, Inc.KYMRNASDAQ
Loading
Cash Flow PerformanceNormalizing
Percentile Rank57
Studio
Year-over-Year Change

Free cash flow yield

Percentile
P57
Within normal range
vs 5Y Ago
-1.2x
Contraction
Streak
3 yr
Consecutive growthNormalizing
PeriodValueYoY Change
2025-3.57%+48.0%
2024-6.87%+25.7%
2023-9.24%+20.2%
2022-11.58%-170.3%
2021-4.28%-249.8%
20202.86%+143.9%
20191.17%+190.4%
2018-1.30%-